Abstract
The optimization and kinetic of rosmarinic acid extraction from Orthosiphon stamineus were investigated in this study. In the preliminary study, the extractions were carried out to identify the optimal ethanol concentration. Then, the optimal ethanol concentration was used to optimize the extraction variables (solventto- solid loading ratio, temperature and time) by central composite design. The optimum conditions for the rosmarinic acid extraction were at the concentration of ethanol, 70% v/v; solvent-to-solid loading ratio, 9.14; extraction temperature, 56.53°C; and extraction time, 3 hours. Subsequently, this study used six proposed models to describe the kinetic of the rosmarinic acid extraction. Two-site kinetic model gave the best fit for the experimental data with the highest coefficient of determination, R2 (0.976) and the smallest values of root mean square error (RMSE) (1.522). The goodness of fit is due to the presence of the rate constants of both fast and slow released fractions in the model. Hence, two-site kinetic model is the most appropriate model to describe the rosmarinic acid extraction from O. stamineus in a reflux extraction system.
Keywords: Central Composite design, extraction, kinetic modeling, Orthosiphon stamineus, response surface methodology, rosmarinic acid.
Current Bioactive Compounds
Title:Optimization and Kinetic Modeling of Rosmarinic Acid Extraction from Orthosiphon stamineus
Volume: 10 Issue: 4
Author(s): Cher H. Lau, Lee S. Chua, Chew T. Lee and Ramlan Aziz
Affiliation:
Keywords: Central Composite design, extraction, kinetic modeling, Orthosiphon stamineus, response surface methodology, rosmarinic acid.
Abstract: The optimization and kinetic of rosmarinic acid extraction from Orthosiphon stamineus were investigated in this study. In the preliminary study, the extractions were carried out to identify the optimal ethanol concentration. Then, the optimal ethanol concentration was used to optimize the extraction variables (solventto- solid loading ratio, temperature and time) by central composite design. The optimum conditions for the rosmarinic acid extraction were at the concentration of ethanol, 70% v/v; solvent-to-solid loading ratio, 9.14; extraction temperature, 56.53°C; and extraction time, 3 hours. Subsequently, this study used six proposed models to describe the kinetic of the rosmarinic acid extraction. Two-site kinetic model gave the best fit for the experimental data with the highest coefficient of determination, R2 (0.976) and the smallest values of root mean square error (RMSE) (1.522). The goodness of fit is due to the presence of the rate constants of both fast and slow released fractions in the model. Hence, two-site kinetic model is the most appropriate model to describe the rosmarinic acid extraction from O. stamineus in a reflux extraction system.
Export Options
About this article
Cite this article as:
H. Lau Cher, S. Chua Lee, T. Lee Chew and Aziz Ramlan, Optimization and Kinetic Modeling of Rosmarinic Acid Extraction from Orthosiphon stamineus, Current Bioactive Compounds 2014; 10 (4) . https://dx.doi.org/10.2174/157340721004150206151452
DOI https://dx.doi.org/10.2174/157340721004150206151452 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis and Biological Evaluation of Novel N-[(7-pyridin-4-yl-2, 3- dihydro-benzofuran-2-yl) Methyl]-(4-methyl-1, 2, 3-thiadiazole-5-yl) Formamide as a Potent Immunosuppressant Agent
Letters in Drug Design & Discovery Production and Purification of Functional Lipids Through Enzymatic and Microorganism-Mediated Processes
Current Organic Chemistry Leukocyte Traffic Blockade as a Therapeutic Strategy in Inflammatory Bowel Disease
Current Drug Targets Evaluation of Pregabalin Therapy in Peripheral Neuropathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Regulation of Multidrug Resistance by Pro-Inflammatory Cytokines
Current Cancer Drug Targets Modifier Gene Studies to Identify New Therapeutic Targets in Cystic Fibrosis
Current Pharmaceutical Design Inhibition of Matrix Metalloproteinases as a Feasible Therapeutic Target in Rheumatoid Arthritis
Current Rheumatology Reviews Monoclonal Antibodies: A Review
Current Clinical Pharmacology No Association of MicroRNA-146a rs2910164 Polymorphism and Risk of Primary Gout Development in Chinese Han Populations: A Case-control Study
Current Rheumatology Reviews Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Biotechnology COVID-19: Role of Robotics, Artificial Intelligence and Machine Learning During the Pandemic
Current Medical Imaging Circulating Biomarkers Determining Inflammation in Atherosclerosis Progression
Current Medicinal Chemistry Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications
Current Medicinal Chemistry The Potentials of Selected Therapeutic Targets for Inflammation: A Snapshot
Recent Patents on Inflammation & Allergy Drug Discovery Therapeutics and Carriers: The Dual Role of Proteins in Nanoparticles for Ocular Delivery
Current Topics in Medicinal Chemistry Inhibiting Protein-Protein Interactions as an Emerging Paradigm for Drug Discovery
Mini-Reviews in Medicinal Chemistry Ibandronate in Benign Bone Disease
Reviews on Recent Clinical Trials Cytokine Status of Serum in Ovarian Cancer Patients with Different Tumor Neoadjuvant Chemotherapy Response
Anti-Cancer Agents in Medicinal Chemistry Phenomics of Vascular Disease: The Systematic Approach to the Combination Therapy
Current Vascular Pharmacology Recent Advances in PDE4 Inhibitors as Immunoregulators and Anti- Inflammatory Drugs
Current Pharmaceutical Design